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Summary.-A simple method of calculating the best ages for carrying out cervical
cytology screening procedures is proposed. The argument is graphical, the out-
comes are readily understood by visual and intuitive methods, but a computer
program for assisting the calculations is constructed. Use of the method indicates
that relatively high rates of screening should be employed in women over45, and that
routine screening in women under 30 years of age is likely to be ineffective in reducing
mortality. The method predicts that, if we assume a negative error rate for the test
of 0-2, and a natural history with a mean interval between detectability and in-
curability of about 6 years, a series of 10 tests deployed between 35 and 80 years in
England and Wales should give a yield of 0.67 deaths saved per 1000 tests performed,
and should be capable of saving about 77%o of all deaths from cervical cancer in
women who conform with the recommendation.
FORMULATING the best ages and
frequencies for cervical cytology screening
requires a knowledge of a range of facts.
This includes information on, (a) the onset
rates and natural histories (i.e. durations
and rates ofchange) ofthe various cervical
pathologies, and their variations with age,
(b) the negative and positive error rates of
the cytological test with respect to each
of these stages, (c) levels of acceptability
in each age group, (d) the effectiveness of
treatment at each stage, (e) the cost ofthe
various procedures used and, (f) an assess-
ment of available material and financial
resources. With such a range of infor-
mation it would be possible to calculate
the investment necessary to achieve a
given (and feasible) level of control, or
alternatively, the level of control possible
for a given level of investment and mode
of deployment. An approach to the
necessary computational processes has
been presented by the present author
(Knox, 1973; 1975).
Unfortunately, not all this factual
material is available: there is disagreement
about theerrorrates, and aboutthenatural
histories of dysplasia and carcinoma in
situ, in particular. Repetition of the
calculations is therefore necessary for each
set of alternative " facts ", and the com-
putations are complex and tedious. This
is ofno great importance when a computer
is used, but their complexity removes the
procedure from ready intuitive appreci-
ation, and the wide choice of alternative
results for alternative premises reduces
the precision of the guidance which can be
obtained.
The question therefore arises, whether
a simplified approach may be able to
circumvent some of the uncertainties and
differences of opinion, and some of the
complexity of the computation, at an
acceptable cost. This cost will consist of
a loss of detail and comprehensiveness in
predicting the con.sequences of proposed
policies, but it might be possible to hold
the costs at an acceptable level while
providing an adequate interim statement
of an optimal strategy. The develop-
ment, demonstration and usage of a
simplified basis for this process is the
purpose for the present paper.
Two main simplifications of method
are adopted in this approach.AGES AND FREQUENCIES OF SCREENING
First simplification
The first simplification is the abandon-
ment ofany consideration ofacceptability.
That is, uncertainty about levels of
acceptance at different ages, is circum-
vented by assuming that all women in the
population will attend. The calculated
consequences ofproposed policies therefore
apply only to those women who act upon
the recommendations. Predicting the
effect upon total population mortality
requires additional computation.
Second simrplification
The second simplification is designed
to circumnvent uncertainties and differences
of opiniioIn about the proportions of
dysplasias aind carcinomas in situ which
progress to invasive disease, and the way
these proportions may vary with age,
between countries, or between laboratories
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responsible for the diagnoses. This is
achieved by taking account of the natural
history only in those women who do in
fact progress to invasive cancer in the
absence of screening. The cost of this
simplification is a loss of any commentary
upon the numbers of false positives and of
unnecessary biopsies; its benefit is that the
predictions now depend upon a limited
zone of uncertainty, the natural history of
disease in a smaller and closely defined
group ofwomen.
WTe may, indeed, narrow the uncer-
tainties further; because screening services
are in practice superimposed upon existing
diagnostic and treatment services, and
theirbeniefits areinthis sense " marginal ":
we may limit ourselves to the women who
(in the absence of screening) die. Screen-
ing services may of course hope in addition
to reduce the extent of treatment neces-
sary to save the lives of those who are
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Screening Frequency (per year) = VIs
Flc.I .-Percent detection for different screeninig frequencies (1/,s) assuming 3-, 5-, 10-, 15-year detectability
intervals (A), and 10000 sensitivity of test.
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saved anyway, but this can be regarded
as a bonus over and above the prime
objective.
Retrospective natural histories in women
who die
We do not know exactly what the
natural histories of these women have
been, and we shall still have to plan our
recommendations against a range of
alternative possibilities. The stages ofthe
natural history with which we are con-
cerned are: (i) the duration of the interval
(A) between the point at which the disease
first becomes detectable and the point at
which it becomes incurable, and (ii) the
duration of the interval (B) between
incurability and death. Interval A might
also be sub-divided at the point where the
disease ceases to be easily curable, but for
the time being, and in the spirit of
simplifying the problem, we shall regard
it as homogeneous.
Ifa group ofwomen could be identified
with a constant Interval A of (say) 5 years,
then a screening frequency (Interval S)
of once in 5 years would detect every case,
providedthatthetestwere 1000%sensitive;
shorter screening intervals could detect no
more. Longer screening intervals would
detect a proportion of cases equal to the
ratio A/S. Thus, a 10-year screening
interval would detect half of the cases, a
15-year interval one-third.
The relationship is expressed in Fig. 1,
where the proportion of cases detected
(vertical scale) is given for different
screening frequencies (horizontal scale), as
well as for alternative values ofInterval A
(different lines). The horizontal scale is
most conveniently expressed as frequency,
which is the reciprocal ofscreening interval
(i.e. 1/S) for the two reasons: (i) with this
scale-transformation the relationships are
linear below the critical point where
S A, and (ii) the scale of frequency is
roughly equivalent to " cost ", and can be
matched against the vertical scale, which
is roughly equivalent to " benefit ".
Screening Frequency (peryear).vs
FiIG. 2. Percent detection for different screening frequencies (l/s) and different detectability intervals
asstuming 80% sensitivity of test.
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The effects of a realistic negative error
rate are shown in Fig. 2. For all values
where A < S, the slopes are simplylowered,
in simple ratio with the negative error rate
(e.g. 20% in the figure). As the interval S
falls below the interval A an increasing
proportion of women receive double in-
vestigations, and this proportion rises
until S A/2, when all of them do. At
this point the cumulative error rate may
be taken as 0.202, or 004 (4%0) and the
curve will pass another sharp bend,
heading for a total error of 0 203, when
S - A/3, and so on. At these levels the
deductions are rather schematic since we
have in fact no guarantee or even likeli-
hood that the probability of being missed
on one occasion is independent of the
probability of being missed on the next.
Common sense would suggest that difficult
cases will remain difficult cases and to this
extent the upper parts of the curves in
Fig. 2 might be regarded as optimistic.
It must be said that, at present,
we have no completely reliable esti-
mates of the negative error rate or of
the length of Interval A, or of its distri-
bution, or how it might vary with age. It
may be misleading, for example, to trans-
pose to this context any estimates derived
from repeated cervical smears in general.
They may not represent the findings
among those women who die. To be
cautious, we have to examine a range of
contingencies and calculate conditional
conclusions for each chosen premise. For
example, if the negative error rate is 0.2
and the mean Interval A is (as is widely
believed) around 10 years, then women
accepting a 5-year-interval regime will be
detected in a curable stage in about 9500
of cases. Even the women with more
rapidly developing lesions will receive
substantial benefit from such a regime
(see Fig. 2), amounting to 80% of those
with a 5-year interval, and nearly 5000 of
those with a 3-year interval between
detectability and incurability.
Interaction offrequency with age
Two important questions are not
answered by the approach represented in
Figs. 1 and 2 and they are (a) "At what
age should we begin" and (b) "At what age
should we stop?" In addition, because
resources are limited and because absolute
safety is not a practicable aim, "What
improvements might be had from varying
Interval S according to circumstances?"
The frequency of screening might be
varied in terms of geography, social class,
parity, age or some combination, in such a
way that higher screening frequencies are
used where the opportunity ofinterrupting
malignant histories is greater. So far as
age is concerned, these opportunities are
distributed in a manner dependent upon
the observed distribution of ages at death,
modified according to some pre-dating
formula. The degree of pre-dating, like
the frequency of screening, is determined
in part by the natural history and the test
should precede the mortality against which
it is aimed by a gap of length somewhere
between B (the interval between incurabi-
lity and death), and A + B (the total in-
terval between first detectability and
death). The procedure would be effective
in preventing deaths following it within
these limits, and it might therefore be
reasonable to locate each screening proce-
dure at a gap of (B + A/2) before the
mortality against which it was aimed. The
argument envisages an unchanging morta-
lity with age, which is not true, but at
low frequencies of screening (where S > A
and the proportion of lives saved is
linearly related to investment) an age-
specific curve of optimal screening
frequency would, to a first approximation,
resemble the mortality curve, ante-dated
by such a gap.
If the main concern were to save life-
years rather than lives, the curve of
mortality could first be multiplied by
eo-values, taken from the current female
life-table, to give an age-specific curve of
life years lost per thousand population per
annum, from this disease. Age-specific
curves of mortality and of life-years-lost
are given in Fig. 3.
If we wish to avoid a value judgment
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FI-. 3. Age distribution of mortality rates an(1 other meastures of loss for
cancer of cervix in England an(l Wales.
which can have no exact solution, there
are other possibilities. The third curve in
Fig. 3 is a compromise obtained by multi-
plying mortality by the square root of life
years lost; that is, long survivals are not
weighted in proportion to their length.
While the deployment of small invest-
ments can be guided by such curves,
suitably antedated, investments which
enter the non-linear parts of the cost-
benefit relationship complicate the arith-
metic, although not the principles, and
require an extended quantitative treat-
ment.
Before proceeding in this direction,
however, there is one further qualitative
conclusion that can be drawn regarding
the age/frequency interaction. It is evi-
dent that the assumption of a relatively
long Interval A has the joint effect of
requiring less frequent examinations for a
given result, and ofrequiring examination
at earlier ages: conversely, a short Interval
A requires more frequent examinations,
and at later ages. In these terms, there-
fore, recommendations for both early and
frequent examinations appear to be based
upon contradictory premises and there are
no grounds, in terms of direct savings, for
accepting recommendations of this kind.
Annual examinations of young women
receiving prescriptions for oral contracep-
tives would seem a particularly non-cost
effective approach and a waste of scarce
resources. Even for women in known
high-risk groups (high parity, venereal
disease clinics, prison populations etc.),
where a higher-than-average overallinvest-
ment may be justified, the relatively high
frequencies of surveillance appropriate in
younger women, should be followed by
even more frequent surveillance as they
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get older. The only modifications of this
policy would arise from a different age
distribution of mortality, or a different
natural history, if these could be demon-
strated. Since we do not know whether
the average Interval A is long or short or
what the range might be, there could be
justification for covering both possibilities.
Even here, however, the requirements
would be for long screening intervals in
younger women and shorter screening
intervals in older women.
Quantitative relationships
Forthepurposesofplanningarelatively
low level ofinvestment, we might do worse
than use the compromise curve of Fig. 3,
pre-dated according to the formula (B +
A/2) by about 8 years (B 3, A 10, for
example). Screening would then begin at
about age 30-35, and from about age 42
would be supplied at regular intervals.
Because ofthe linearity ofthe relation-
ship between benefit and cost (for achieve-
ment levels below 80%) it would always
be profitable, in the early stages of a
growing service, to increase the screening
frequency at ages ofhigh risk (i.e. 45+) to
the point where A S, before expending
any resources at earlier ages. As soon as
the screening interval at these ages
equalled Interval A, progressively earlier
ages would be screened, until an age group
was reachedwhoserisklevelwasaboutone-
sixth of that in the high-risk ages. At
this point it would become profitable,
once more, to increase the screening
frequency in the high-risk groups. This
is because the slopes in the upper parts of
Fig. 2, representing the marginal benefit/
cost ratios at higher investment levels, are
about one-sixth of the slopes in the lower
parts of the curves. By the time that
first screening at ages under 30 became
justifiable, the screening intervals at ages
over 45 would most profitably have been
reduced to A/2.
Age (years)
FIG. 4. Effect upon weighted mortality index mN ,'eO of sequential screening tests.
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The above considerations refer to a
fixed Interval A, and a particular formu-
lation of benefit. With other choices, and
with a mixed population encompassing a
range of Intervals A, the solution is more
complex, and it would be difficult in our
present state of ignorance to state the
exact levels of investment at which an
earlier deployment would be desirable.
However, there is no doubt about the
qualitative characteristic of the result,
which is that screening before the age of
30 has relatively little value. Any effec-
tive pattern of deployment within the
scale ofresources currently and foreseeably
available in the United Kingdom would
consist of a low to moderate frequency of
screening between the ages of 30 and 45
and a higher steady level thereafter. A
programme deployed in this pattern could
expect to produce relatively good results
with moderate investments, the exact
level depending upon the natural history
and the error rate. The benefits ofsuch a
policy should begin to appear at an
Interval B after their inception.
The results of a cost-effective policy
which attempted to relate the age/
frequency of screening to subsequent
(i.e. after B + A/2) mortality levels, can
be demonstrated visually by a simple
graphic method. This is shown in Fig. 4.
Each test, after an interval of B, produces
a deep cut in the mortality, proportional
in depth to the sensitivity of the test.
The cut persists for a period A, and ends.
Closely set tests involve some waste
because of overlap, but later tests cut by
the same proportion into the cases missed
by earlier tests. The curve used for this
demonstration in Fig. 4 is again the
"compromise " curve of Fig. 3, based
upon (mortality x A/eO). This demon-
stration refers to a fixed Interval A, and a
fixed Interval B, and a more realistic
model would repeat the graphical exami-
nation for a range ofA and B occurring in
specified proportions. An adaptation of
the graphical techniques for this purpose
can be envisaged and may not in practice
be prohibitive in time and effort. Never-
theless, it takes only a simple computer
program to set up a family of such graphs
and to accumulate the effects ofa range of
age/frequency policies set against a variety
of natural histories and a variety of error
rates. A program of this simplicity,
requiring only simple inputs, and readily
understood in visual terms, possibly meets
the main objectives ofthis paper. Such a
program was written and is available.
Practical recommendations for England
and W1'ales
In England and Wales at the present
time about 2-6 million cervical smears are
TABLE-Deaths Savedper 1000 Testsfor Different Natural Histories:
Negative Error Fixed at 0-2
Interval S Ages
C25-70
5 30-75
L35-80
r24-60
4 32-68
40-76
20-47
3 32-59
44-71
r26-44
2 38-56
50-68
20-29
30-39
1 40-49
50-59
L60-69
A=3
0 44
0 50
0 54
0 39
0 51
0 60
0-19
0 40
0-51
0 17
0 37
0 -41
001
0 08
0-22
0-25
0-23
A= 15
0-76
0 79
0-83
0 66
0 75
0 75
0 45
0-66
0 66
0-42
0-60
0 54
0-10
0 33
0 45
0 45
0 34
Natural Histories
A=4
0 50
0-56
0-60
0 40
0-51
0 59
0-21
0 43
0-52
0-18
0-38
0-41
0-01
0-10
0 24
0 27
0-25 0-27 0-30
A=6
0 57
0-63
0-67
0 47
0 59
0-65
0 -26
0-48
0-56
0-23
0 43
0 45
0 02
0-14
0-28
0 31
A= 10
0-68
0 73
0 77
0 57
0-67
0 72
0 35
0 57
0-62
0 -31
0 50
0 49
0 05
0-22
0-36
0 37
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carried out annually (DHSS, 1975). Of
these, a proportion represents investi-
gations of women presenting with symp-
toms to their doctors, while others are
repeats of unsatisfactory specimens, but
about 2-0 million, probably, are used for
screeningpurposes. Thesetestsareshared
among an adult female population, aged
20 to 85, of 17-6 million, thus allowing a
" ration " of about 1 test every 9 years, or
about 7/woman/lifetime. However, not
all women can be persuaded to attend, and
it would be reasonably safe to offer the
service at a higher frequency. It is
suggested for purposes of the present
exercise that an offer might be made
corresponding to an average of 10 tests/
woman/lifetime and an examination made
of their alternative deployments.
In the Table the results of a number of
alternative deployments of 10 tests are
provided against a range of different
assumptionsrelatingtoIntervalA. Inter-
val B was also varied in preliminary tests
but was found, as might be expected, to
make little difference. In the Table it has
been held constant at 3 years, as has the
negative error rate, at a value of0-2. The
first 2 columns of results refer to fixed
length Intervals A, a short one of 3 years
and a long one of 15 years. The last 3
columns of results refer to populations
exhibiting a range ofInterval A with mean
values as shown, namely 4, 6, and 10 years
respectively. The first of these popu-
lations consisted of 5 sub-populations,
with Intervals A of 1, 2, 4, 6, 7 years in
proportions 10, 20, 40, 20, 10%, respec-
tively. In the second population, inter-
vals of 1, 3, 6, 9, 11 years were distributed
in similar proportions. In the last popu-
lation the intervals were 3, 5, 10, 15 and
17 years, again in the same proportions.
The main panels of the Table show results
corresponding to different spacings oftests,
from 5 years down to one year. Within
each panel the effects of differing age
ranges are displayed. In this table, bene-
fits are describedl as the numbers ofdeaths
saved per thousan(d tests perfor-med. The
following features appear. First, the
31
longer natural histories give more favour-
able results than the shorter natural
histories. Second, wider spacings of a
fixed number of tests give better results
than narrower spacings. Thirdly, with
the exception of the oldest age groups of
the closest spacings, the numbers ofdeaths
saved are greater when the tests are
concentrated upon the higher age ranges.
Fourthly it can be seen that a very wide
range of results can be obtained from
different deployments ofthe sameresource,
the range itselfdepending upon the natural
history. For example, if we assume that
the natural history distribution centred
upon a mean Interval A of 6 years is the
correct one, a 5-year spacing of tests
beginning at age 35 gives something like
30 times the benefit of a one-year spacing
beginning at age 20 and ending at age 29.
These ranges are less marked if we use
criteria other than deaths saved. How-
ever, benefits assessed in terms of life
years, or in terms ofthe modified life years
index described earlier, both showed
gradients in the same general directions.
The real meaning of the rates given in
the Table can be represented in more
extended form as follows. Confining our-
selves to the natur-il history distribution
centred upon a meat Interval A of 6 years
and an error rate of 0-2, a 2-year spacing
of tests between ages 26 and 44 gives a
useful yield of 0-23 deaths saved per 1000
tests performed. If this were applied to
the total female population of England
and Wales it would result in a saving of
670 deaths per annum from an original
total of 2250, a reduction of 298%. At
the same time, the life years lost to this
disease would be reduced by 44.4% and
the weighted index of life years by 37-2%.
Onthe otherhand, a 5-year spacing oftests
from ages 35 to 80 gives a useful yield of
almost 0-67 deaths saved per 1000 tests
performed. This is an absolute saving of
1750 deaths saved, amounting to 77.8%
ofall deaths. The proportion oflife years
saved is 75 1 00, and ofthe weighted index,
76 3°0.
Finally, an iterating version of the
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programme was written so designed that,
when an initial deployment is proposed,
a series of incremental modifications is
tried and tested automatically until no
further improvement is obtained. Using
the same natural history, and an error rate
of 0-2, the optimal distribution of 10 tests
for maximizing the number of deaths
saved per 1000 tests performed, was at
ages 35, 40, 44, 48, 51, 54, 61, 68, 75 and
80. The returns amount to 0-67 deaths
saved per 1000 tests and, applied to the
whole female population of England and
Wales would have saved 77.2% of all
deaths (1736, absolutely) for 2-61 million
examinations. 76.2% of life years lost to
this disease would be saved; 76 6% of the
weighted life-years index.
Alteration of the estimate for the
negative error rate changed the yield for a
given investment but did not substantially
alter the optimal age-distribution for the
tests. For a negative error rate of 0 I the
optimal age-distribution was at ages 33,
40, 44, 48, 51, 54, 61, 75 and 80: 83% of
deaths were saved and the yield was 0-71
deaths saved per 1000 tests. When the
negative error rate was increased to 0 3
the optimal age distribution turned out at
ages 36, 40, 44, 48, 51, 54, 61, 67, 73, 80.
The proportion ofdeaths saved was 71.6%
and the yield per 1000 tests was 0-61
deaths saved.
Alterations of the criterion for maxi-
mization also resulted in relatively minor
changes. Maximization oflife years saved
per 1000 tests (with a return to the
negative error rate estimate of 0.2)
resulted in an optimal distribution at ages
35, 40, 44, 48, 51, 54, 59, 66, 73 and 80.
77.8% of deaths were saved and 77.0% of
life years. Maximization of weiglhted
life years saved per 1000 tests indicated an
optimal distribution at ages 35, 40, 44, 48,
51, 54, 61, 68, 75 and 80: exactly the same
as for maximization of deaths saved per
1000 tests.
All these results depend upon the
assumption ofconstancy ofnatural history
in women of different ages, and a more
complex model, allowing for variation,
would certainly give different results.
For example, if the retrospective natural
history of women who die late in life were
longer than that in women who die early,
there would be advantages in closing up
some of the earlier intervals and reducing
the investment at the later ages.
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